Triple Combination Antiviral Therapy

Kaur Simaranjit; Kaur Kuldeep; Kaur Herbaksh

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Triple Combination Antiviral Therapy

Author(s): Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh

Email(s): onlyharsh24@gmail.com

DOI: Not Available

Address: Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh
Assistant Professor, M.M College of Nursing, Mullana Ambala, Haryana
*Corresponding Author

Published In: Volume - 7, Issue - 10, Year - 2014

View HTML

View PDF

ABSTRACT:
Combination antiviral therapy helps to prevent the virus that causes hepatitis C from reproducing in the body along with HIV. Peg interferon and Ribavirin are combined to give the best response to treatment in case of HIV Positive. A protease inhibitor (such as Boceprevir or telaprevir) also may be given along with peg interferon and Ribavirin. Combination antiviral therapy is prescribed for those who have ongoing (chronic) hepatitis C infection. This therapy has certain side-effects that comes with medicine. Usually the benefits of the medicine are more important than any minor side effects i. e Fatigue, headache, muscle and joint aches etc. Periodic liver function tests and a liver biopsy every 3 to 5 years come in the special considerations. Follow-up care is a key part of treatment and safety. One has to be sure to make and go to all appointments, and call the doctor if there is any problem.

Keywords:

Combination Antiviral Therapy.

Cite this article:
Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh. Triple Combination Antiviral Therapy. Research J. Pharm. and Tech. 7(10): Oct. 2014 Page 1190-1192.

Recomonded Articles:

Prosthodontic Considerations of Speech in Complete Denture

Author(s): Jarkas Manar

DOI: 10.5958/0974-360X.2018.00945.9 Access: Open Access Read More

Triple Combination Antiviral Therapy

Author(s): Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh

DOI: Not Available Access: Open Access Read More

Essential Concepts of Mobile Phase Selection for Reversed Phase HPLC

Author(s): V. Agrahari, M. Bajpai, S. Nanda

DOI: Not Available Access: Open Access Read More

An Overview on Good Pharmacovigilance Practices and New Operational Plan Milestones of Eudravigilance in European Union

Author(s): A. S. Sathya Narayanan, K. S. Lakshmi, Raju Kamaraj

DOI: 10.5958/0974-360X.2020.00323.6 Access: Closed Access Read More

Analytical Validation Strategies for DBS Biomarker Assays

Author(s): Elizabeth Mary Mathew, Pragna Rao, Raghavendra Shetty, Leslie Lewis, Sudheer Moorkoth

DOI: 10.5958/0974-360X.2019.00695.4 Access: Open Access Read More

Review on the formulation considerations needed to produce a stable Self micro Emulsifying Drug Delivery System (SMEDDS)

Author(s): Ashok Chandrakar, Bishesar Sahu, Homendra Sahu, Jagdish Dewangan, Navin Kumar, Rajat Singh, Rohit Gupta, Devesh Kumar, Bhishm Sahu, Kuldeep Dewangan, Rishi Kaushal, Mukta Agrawal, D. K. Tripathi, Ajazuddin, Amit Alexander

DOI: 10.5958/0974-360X.2017.00275.X Access: Open Access Read More

Alternatives to In vivo Experiments – A Pandect

Author(s): Fatima Grace Xavier, Anbarasan Balu, Shanmuganathan Seetharaman, Akila Lakshmikandhan, Arul Amutha Elizabeth Lawrence

DOI: 10.5958/0974-360X.2019.00786.8 Access: Open Access Read More

Pharmaceutical Considerations behind the Development and Evaluation of Mucoadhesive Tablets

Author(s): Rashmi Verma, Yamini Dewangan, Lokeshwari Sahu, Barkha Dongre, Khushboo Mishra, Trilok Patel, Sakhram Nishad, Ashish Damle, Ghanshyam Sahu, K. DeviRao, MithleshPatle MuktaAgrawal, D. K. Tripathi, Ajazuddin, Amit Alexander

DOI: 10.5958/0974-360X.2017.00220.7 Access: Open Access Read More